Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Acadia Pharmaceuticals buy Cantor Fitzgerald

Start price
€21.80
28.02.24 / 50%
Target price
€38.75
28.02.25
Performance (%)
-28.37%
Price
€15.62
26.04.24
Summary
This prediction is currently active. The prediction for Acadia Pharmaceuticals disappoints with a performance of -28.37%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Acadia Pharmaceuticals 0.807% 0.807%
iShares Core DAX® -0.992% -3.231%
iShares Nasdaq 100 -0.225% -3.339%
iShares Nikkei 225® -0.736% -7.859%
iShares S&P 500 -0.509% -2.979%

Comments by Cantor_Fitzgerald for this prediction

In the thread Acadia Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -28.37%
Target price 38.753
Change
Ends at 28.02.25

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $42.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat

Stopped prediction by Cantor_Fitzgerald for Acadia Pharmaceuticals

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€15.79
30.04.24
€34.52
30.04.25
0.00%
26.04.24

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€16.50
10.04.24
€34.38
10.04.25
-5.36%
26.04.24

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€23.60
02.02.24
€38.87
02.02.25
-33.83%
26.04.24

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€25.60
14.12.23
€38.21
14.12.24
-39.00%
26.04.24